Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 01, 2026
TickeronGET DAILY SIGNALS
Estée Lauder (EL): Q3 Earnings Preview Amid Beauty Reimagined Progress

Estée Lauder (EL): Q3 Earnings Preview Amid Beauty Reimagined Progress

Key Takeaways

  • Analysts expect Q3 fiscal 2026 revenue of $3.69 billion, implying about 4% year-over-year growth.
  • Consensus EPS estimate stands at $0.65 per share, roughly flat compared to the prior year.
  • Following a strong Q2 with 4% organic sales growth and adjusted EPS of $0.89, the company raised FY2026 guidance.
  • Investors are watching Mainland China sales, projected for mid-single-digit full-year growth, and skincare category momentum.
  • Stock has declined post-earnings in 10 of the last 12 reports, signaling potential volatility.
  • Tariff headwinds estimated at $100 million for FY2026, mostly in the second half.

Earnings Context and Why It Matters

Estée Lauder Companies' (EL) fiscal 2026 third quarter earnings, covering January through March, arrive as part of its "Beauty Reimagined" turnaround strategy. From what I see, after a tough stretch with weak demand in China and travel retail, the Q2 results marked real progress—organic net sales grew 4%, fueled by skincare and fragrance. This report matters because it will shed light on cost-cutting efforts, including up to 7,000 job reductions, and margin improvements. For investors like us, it's a key check on whether prestige beauty demand is recovering, particularly in Asia, against a backdrop of economic uncertainty and tariff risks. Solid execution here could solidify the raised full-year outlook, but any hiccups might add pressure to shares that are already down over 25% year-to-date.

Earnings Expectations

Wall Street looks for Q3 revenue of $3.69 billion, up 3.91% year-over-year per 16 analysts. The EPS consensus is $0.65 from 19 analysts, suggesting stability from last year. I'll be paying close attention to organic net sales growth, projected in the low-single-digits for the second half, and adjusted operating margins, which are expected to dip about 50 basis points from investments and tariffs. I also checked this using Tickeron’s AI Screener to gauge how EL stacks up against peers.

The backdrop from recent quarters is encouraging but mixed: Q2 net sales hit $4.23 billion (up 6%) with adjusted EPS of $0.89, topping estimates and leading to raised FY2026 guidance of 1%-3% organic sales growth and $2.05-$2.25 adjusted EPS. Q1 also beat on revenue and earnings. That said, EL shares have a history of dropping after earnings—down following 10 of the last 12 reports—highlighting the market's emphasis on guidance and trends like China.

AI Screener

One tool I use regularly in my analysis is Tickeron’s AI Screener. It's an AI-powered platform for discovering stocks and ETFs by filtering on technical patterns, fundamentals, trends, volatility, and AI signals. I appreciate how it lets me scan thousands of names with custom filters like industry, market cap, indicators, and performance metrics to spot trade ideas, breakouts, or opportunities in sectors like consumer goods—saving time over manual work.

Market Reaction and Investor Sentiment

Sentiment heading into earnings feels cautiously optimistic after Q2's strong showing, though tariff concerns and ongoing China/travel retail issues temper expectations. Implied volatility points to an 8-10% potential move post-report, consistent with history where shares fell after 10 of 12 prior earnings. Risks like weaker Asia Pacific sales or cautious guidance could weigh on the stock, but skincare beats and upbeat China updates might drive a rebound. EL is trading around $77, well off its highs amid prestige beauty sector strains.

Forward Outlook and Key Factors to Monitor

Keep an eye on any tweaks to FY2026 guidance: 1%-3% organic net sales growth and $2.05-$2.25 adjusted EPS, plus $1.1-$1.2 billion in operating cash flow. Updates here will show how "Beauty Reimagined" is tracking.

Mainland China is crucial—Q2 saw double-digit retail sales growth, but full-year projections are mid-single-digits. Momentum in skincare (up 6% organically in Q2) and fragrance, despite Northern Asia travel retail weakness, will be telling.

Cost controls remain essential amid restructuring for efficiency and tariff hits of about $100 million (mostly second half), which could squeeze margins. Track adjusted operating margins (9.8%-10.2% full-year target) and inventory for demand clues. Broader items like Q4 holidays, peer results, analyst days, or M&A could influence the story around a sustainable recovery. I'm watching this closely.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


EL in upward trend: price rose above 50-day moving average on October 09, 2026

EL moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on EL as a result. In 47 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.

The Moving Average Convergence Divergence (MACD) for EL just turned positive on November 04, 2026. Looking at past instances where EL's MACD turned positive, the stock continued to rise in 31 of 48 cases over the following month. The odds of a continued upward trend are 65%.

The 10-day moving average for EL crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +6.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in 181 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 139 of 214 cases where EL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for EL moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 24 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 56 cases where EL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

EL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.018) is normal, around the industry mean (21.072). EL's P/E Ratio (210.780) is considerably higher than the industry average of (16.552). Projected Growth (PEG Ratio) (2.121) is also within normal values, averaging (1.518). Dividend Yield (0.013) settles around the average of (0.033) among similar stocks. P/S Ratio (2.317) is also within normal values, averaging (1.902).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 24.68B. The market cap for tickers in the group ranges from 60.48K to 376.41B. PG holds the highest valuation in this group at 376.41B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was 4%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 14%. HELE experienced the highest price growth at 26%, while YSG experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 155%. For the same stocks of the Industry, the average monthly volume growth was 146% and the average quarterly volume growth was 84%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers skin care, makeup, fragrance and hair care products

Industry HouseholdPersonalCare

Industry
Household Or Personal Care
Address
767 Fifth Avenue
Phone
+1 212 572-4200
Employees
55000
Web
https://www.elcompanies.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
FormFactor delivered record Q1 fiscal 2026 revenue of $226.1 million, surpassing expectations amid robust semiconductor demand. Non-GAAP gross margins expanded to 49%, reflecting improved operational efficiency and pricing power.
KEYS shares have surged approximately 18% in recent weeks, trading near 52-week highs around $350. Q1 2026 results showed revenue of $1.60 billion, up 23% year-over-year (YoY), with EPS of $2.17 beating estimates.